Update!
The Parsemus Foundation and its social venture subsidiary Revolution Contraceptives, LLC have partnered with NEXT Life Sciences to continue development of the Vasalgel male contraceptive.
Vasalgel has a new home
After a decade of research on Vasalgel, the Parsemus Foundation determined that the reversible, long-lasting male contraceptive was ready to advance to the next level. The search began for an organization with the resources needed to lead the project to the marketplace, including clinical trials and regulatory review. The Parsemus Foundation selected NEXT Life Sciences, Inc. as that partner. NEXT Life Sciences’ mission is to develop and distribute medical technology that empowers people to choose when and whether to have a child.
For more information, see our blog post and the NEXT press release.
How to stay engaged with Vasalgel
Stay Connected
- Sign up for updates on Vasalgel from NEXT Life Sciences.
Visit the NEXT Life Sciences website
- Visit the NEXT LifeSciences website to get more information on Vasalgel.
Reproductive Health News
Funding for undergrad research on male contraception
The Male Contraceptive Initiative Youth Advisory Board is offering a grant to undergraduate students for research on male contraception. Undergraduate students anywhere in the world
NEXT steps for Vasalgel
The Parsemus Foundation and Revolution Contraceptives LLC are pleased to announce that NEXT Life Sciences, Inc. has been selected to continue development of the Vasalgel
Supporting the future of male contraceptive research
The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud
Funding for undergrad research on male contraception
The Male Contraceptive Initiative Youth Advisory Board is offering a grant to undergraduate students for research on male contraception. Undergraduate students anywhere in the world
NEXT steps for Vasalgel
The Parsemus Foundation and Revolution Contraceptives LLC are pleased to announce that NEXT Life Sciences, Inc. has been selected to continue development of the Vasalgel
Supporting the future of male contraceptive research
The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud
Small grant funding available for undergraduate projects on contraception
The Male Contraceptive Initiative announced that the Youth Advisory Board Undergraduate Project Grant program is accepting applications until September 30, 2021. The grant aims to
